Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4

被引:31
|
作者
van der Mark, Vincent A. [1 ]
Ghiboub, Mohammed [1 ]
Marsman, Casper [1 ]
Zhao, Jing [1 ]
van Dijk, Remco [1 ]
Hiralall, Johan K. [1 ]
Ho-Mok, Kam S. [1 ]
Castricum, Zoe [1 ]
de Jonge, Wouter J. [1 ]
Elferink, Ronald P. J. Oude [1 ]
Paulusma, Coen C. [1 ]
机构
[1] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands
基金
欧盟地平线“2020”;
关键词
P4-ATPase; Phospholipid flippase; ATP8B1; Endocytosis; Innate immunity; Macrophage; P-TYPE ATPASES; TRANS-GOLGI NETWORK; BAR DOMAIN PROTEIN; PLASMA-MEMBRANE; ENDOTOXIN TOLERANCE; CDC50; PROTEINS; BETA-SUBUNIT; CD14; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE;
D O I
10.1007/s00018-016-2360-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P4-ATPases are lipid flippases that catalyze the transport of phospholipids to create membrane phospholipid asymmetry and to initiate the biogenesis of transport vesicles. Here we show, for the first time, that lipid flippases are essential to dampen the inflammatory response and to mediate the endotoxin-induced endocytic retrieval of Toll-like receptor 4 (TLR4) in human macrophages. Depletion of CDC50A, the beta-subunit that is crucial for the activity of multiple P4-ATPases, resulted in endotoxin-induced hypersecretion of proinflammatory cytokines, enhanced MAP kinase signaling and constitutive NF-kappa B activation. In addition, CDC50A-depleted THP-1 macrophages displayed reduced tolerance to endotoxin. Moreover, endotoxin-induced internalization of TLR4 was strongly reduced and coincided with impaired endosomal MyD88-independent signaling. The phenotype of CDC50A-depleted cells was also induced by separate knockdown of two P4-ATPases, namely ATP8B1 and ATP11A. We conclude that lipid flippases are novel elements of the innate immune response that are essential to attenuate the inflammatory response, possibly by mediating endotoxin-induced internalization of TLR4.
引用
收藏
页码:715 / 730
页数:16
相关论文
共 50 条
  • [21] Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways
    Roy, Anjali
    Srivastava, Mansi
    Saqib, Uzma
    Liu, Dongfang
    Faisal, Syed M.
    Sugathan, Subi
    Bishnoi, Suman
    Baig, Mirza S.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 79 - 89
  • [22] Monocyte Toll-like Receptor 4 (tlr4) Signaling Is Essential For Post Thrombotic Upa Expression
    Sharma, Sriganesh
    Kumar, Kiran
    Bamezai, Sharika
    Rocha, Oscar Y. Moreno
    Rocco, Sabrina
    Mangum, Kevin D.
    Luke, Catherine
    Gallagher, Katherine A.
    Moore, Bethany
    Henke, Peter
    Obi, Andrea T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [23] Molecular Dynamics Simulation of Toll-Like Receptor 4 (TLR4) Ectodomain
    Tafazzol, Alireza
    Duan, Yong
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 339A - 339A
  • [24] Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease
    Santin, I.
    Castellanos-Rubio, A.
    Hualde, I.
    Castano, L.
    Vitoria, J. C.
    Bilbao, J. R.
    TISSUE ANTIGENS, 2007, 70 (06): : 495 - 498
  • [25] Toll-like receptor 4 (TLR4): new insight immune and aging
    Hyo-Jin Kim
    Hyemin Kim
    Jeong-Hyung Lee
    Cheol Hwangbo
    Immunity & Ageing, 20
  • [26] Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4)
    Smirnova, Irina
    Poltorak, Alexander
    Chan, Edward K. L.
    McBride, Colleen
    Beutler, Bruce
    GENOME BIOLOGY, 2000, 1 (01):
  • [27] A toll-like receptor 4 (TLR4) variant is associated with asthma severity
    Zhang, Long
    Xu, Ai-Guo
    Zhao, Wei
    Xu, Qin-Fu
    Zhao, Yu-Miao
    Li, Dan-Dan
    Shi, Xiao-Ya
    Zhao, Jun-Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7849 - 7854
  • [28] Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
    Vaez, Haleh
    Soraya, Hamid
    Garjani, Alireza
    Gholikhani, Tooba
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) : 36 - 47
  • [29] Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
    Zhang, Yongsheng
    Liang, Xinjie
    Bao, Xuefei
    Xiao, Wei
    Chen, Guoliang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235
  • [30] Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.
    Rasheed, Humaira
    Topless, Ruth
    Day, Richard
    Kannangara, Diluk
    Williams, Kenneth
    Bradbury, Linda
    Brown, Matthew
    Hill, Catherine
    Lester, Susan
    Rischmueller, Maureen
    Smith, Malcolm
    Andres, Mariano
    Bardin, Thomas
    Doherty, Michael
    Janssen, Matthijs
    Jansen, Tim
    Joosten, Leo
    Perez-Ruiz, Fernando
    Radstake, Timothy
    Riches, Philip L.
    Roddy, Ed
    Tausche, Anne-Kathrin
    Stamp, Lisa K.
    Dalbeth, Nicola
    Liote, Frederic
    So, Alex
    McKinney, Cushla
    Merriman, Tony R.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1294 - S1295